| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
28,052 |
24,992 |
$1.28M |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
15,365 |
13,420 |
$659K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
6,486 |
5,796 |
$451K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
6,528 |
5,741 |
$407K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
4,204 |
3,686 |
$288K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
12,939 |
9,855 |
$238K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
2,791 |
2,520 |
$193K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
936 |
776 |
$69K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
913 |
856 |
$68K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
3,142 |
2,949 |
$46K |
| 92551 |
|
3,564 |
3,128 |
$29K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
962 |
843 |
$29K |
| 3008F |
|
11,617 |
10,119 |
$23K |
| 90670 |
|
3,563 |
3,252 |
$16K |
| 99173 |
|
3,364 |
2,946 |
$15K |
| 99174 |
|
995 |
875 |
$12K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,071 |
998 |
$11K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
978 |
462 |
$10K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
292 |
259 |
$9K |
| 96127 |
|
2,234 |
1,611 |
$6K |
| 83655 |
|
471 |
397 |
$5K |
| 99460 |
|
116 |
91 |
$5K |
| 99177 |
|
800 |
715 |
$5K |
| 90651 |
|
198 |
167 |
$3K |
| 90688 |
|
1,490 |
1,360 |
$3K |
| 99238 |
Hospital discharge day management, 30 minutes or less |
54 |
50 |
$3K |
| 36416 |
|
2,459 |
2,023 |
$3K |
| 85018 |
|
1,208 |
1,002 |
$3K |
| 90698 |
|
1,707 |
1,565 |
$2K |
| 90686 |
|
3,691 |
3,372 |
$2K |
| 90680 |
|
1,468 |
1,350 |
$2K |
| 90734 |
|
68 |
50 |
$1K |
| 94375 |
|
36 |
30 |
$1K |
| 92587 |
|
27 |
21 |
$880.76 |
| 96160 |
|
69 |
58 |
$820.18 |
| 80061 |
Lipid panel |
68 |
50 |
$761.48 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
37 |
30 |
$629.44 |
| 90633 |
|
371 |
306 |
$606.21 |
| 87081 |
|
122 |
115 |
$551.32 |
| 90710 |
|
17 |
12 |
$527.18 |
| 90716 |
|
50 |
44 |
$465.00 |
| 90707 |
|
94 |
82 |
$296.28 |
| 90744 |
|
578 |
491 |
$155.47 |
| 96161 |
|
33 |
12 |
$139.83 |
| 90685 |
|
454 |
430 |
$132.24 |
| 90700 |
|
26 |
25 |
$101.99 |
| 81003 |
|
27 |
25 |
$57.26 |
| 90648 |
|
12 |
12 |
$29.40 |
| 99000 |
|
1,585 |
1,393 |
$3.71 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
14 |
12 |
$1.58 |
| G8417 |
Bmi is documented above normal parameters and a follow-up plan is documented |
702 |
601 |
$0.00 |
| 3210F |
|
236 |
216 |
$0.00 |
| G8712 |
Antibiotic not prescribed or dispensed |
95 |
89 |
$0.00 |
| G8420 |
Bmi is documented within normal parameters and no follow-up plan is required |
3,793 |
3,274 |
$0.00 |
| G8708 |
Patient not prescribed antibiotic |
3,071 |
2,860 |
$0.00 |
| 3351F |
|
1,078 |
886 |
$0.00 |
| 2016F |
|
23 |
19 |
$0.00 |
| 1031F |
|
23 |
19 |
$0.00 |
| 2015F |
|
23 |
19 |
$0.00 |